Purpose. To present the use of intravenous (IV) prostaglandin E1 (PGE1), a powerful vasodilator of the microcirculation, in the treatment of an ischemic diabetic eye. Methods. A 27-year-old diabetic male with ischemic diabetic retinopathy and glaucoma had a decreased visual acuity of no light perception in his right eye (OD) and hand motions in his left eye (OS). He was started on intravenous PGE1 and has been treated for over 4.5 years. Results. The visual acuity in his OD remained unchanged and in his OS improved gradually to 1.5/30. He has been stable for 4.5 years. Conclusions. IV PGE1 may be useful in ischemic diabetic eyes to improve the ocular blood flow and visual acuity. It is safe and tolerated well.
An Ischemic Diabetic Eye Treated with Intravenous Prostaglandin E1 / Robert D., Steigerwalt; Gianni, Belcaro; Nebbioso, Marcella; Antonella, Pascarella; Mauro De, Angelis; M., Rosaria Cesarone. - In: RETINAL CASES & BRIEF REPORTS. - ISSN 1935-1089. - STAMPA. - 8:1(2014), pp. 21-23. [10.1097/ICB.0b013e3182a48a04]
An Ischemic Diabetic Eye Treated with Intravenous Prostaglandin E1.
NEBBIOSO, MarcellaWriting – Review & Editing
;
2014
Abstract
Purpose. To present the use of intravenous (IV) prostaglandin E1 (PGE1), a powerful vasodilator of the microcirculation, in the treatment of an ischemic diabetic eye. Methods. A 27-year-old diabetic male with ischemic diabetic retinopathy and glaucoma had a decreased visual acuity of no light perception in his right eye (OD) and hand motions in his left eye (OS). He was started on intravenous PGE1 and has been treated for over 4.5 years. Results. The visual acuity in his OD remained unchanged and in his OS improved gradually to 1.5/30. He has been stable for 4.5 years. Conclusions. IV PGE1 may be useful in ischemic diabetic eyes to improve the ocular blood flow and visual acuity. It is safe and tolerated well.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
